{{Rsnum
|rsid=6706693
|Chromosome=2
|position=191600872
|Orientation=plus
|GMAF=0.2837
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 42.5 | 50.4 | 7.1
| HCB | 68.6 | 28.5 | 2.9
| JPT | 62.8 | 32.7 | 4.4
| YRI | 47.3 | 41.8 | 11.0
| ASW | 47.4 | 43.9 | 8.8
| CHB | 68.6 | 28.5 | 2.9
| CHD | 61.9 | 34.3 | 3.8
| GIH | 55.4 | 39.6 | 5.0
| LWK | 34.5 | 52.7 | 12.7
| MEX | 56.9 | 37.9 | 5.2
| MKK | 33.3 | 52.6 | 14.1
| TSI | 42.2 | 38.2 | 19.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=A
  |Pval=9E-6
  |OR=1.74
  |ORtxt=[1.362-2.232]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}